HC Wainwright & Co. Reiterates Neutral on Xenetic Biosciencesto Neutral
Benzinga Newsdesk 1 year ago
NewsReiterationAnalyst Ratings
HC Wainwright & Co. analyst Joseph Pantginis reiterates Xenetic Biosciences (NASDAQ:XBIO) from Neutral to Neutral.
HC Wainwright & Co. analyst Joseph Pantginis reiterates Xenetic Biosciences (NASDAQ:XBIO) from Neutral to Neutral.